US · Healthcare

Immunome Inc (IMNM)

Biotechnology

Immunome Inc (IMNM) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for IMNM

P/E ratio

18.00

Immunome Inc (IMNM) — FAQ

What is IMNM's P/E ratio?

The price-to-earnings (P/E) ratio for Immunome Inc (IMNM) is 18.00 (data as of 2026-03-24).

Does Immunome Inc pay a dividend?

Dividend yield is not available in the current snapshot for Immunome Inc (IMNM). Check the MyAverix Finance app for the latest dividend data.

What sector is Immunome Inc in?

Immunome Inc (IMNM) is classified in the Healthcare sector (Biotechnology industry).

What exchange is IMNM listed on?

IMNM is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)